Cencora (COR): Has the Recent Pullback Opened a Valuation Opportunity?

Simply Wall St.12-17 17:26

Cencora (COR) has quietly pulled back about 6% over the past month even as its year to date gain sits above 50%, setting up an interesting check on what has actually changed. See our latest analysis ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592499460?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/24809-main-header/1756252652273","is_english":true,"pubTime":"2025-12-17 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592499460","market":"hk","top_or_hot":-1,"title":"Cencora (COR): Has the Recent Pullback Opened a Valuation Opportunity?","media":"Simply Wall St.","content":"<div>\n<p>Cencora (COR) has quietly pulled back about 6% over the past month even as its year to date gain sits above 50%, setting up an interesting check on what has actually changed. See our latest analysis ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-has-the-recent-pullback-opened-a-valuation-oppor\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cencora (COR): Has the Recent Pullback Opened a Valuation Opportunity?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCencora (COR): Has the Recent Pullback Opened a Valuation Opportunity?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-17 17:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-has-the-recent-pullback-opened-a-valuation-oppor><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cencora (COR) has quietly pulled back about 6% over the past month even as its year to date gain sits above 50%, setting up an interesting check on what has actually changed. See our latest analysis ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-has-the-recent-pullback-opened-a-valuation-oppor\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0058720904.USD","symbol_name":"联博国际健康护理基金A","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-has-the-recent-pullback-opened-a-valuation-oppor","article_id":"2592499460","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/24809-main-header/1756252652273"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-has-the-recent-pullback-opened-a-valuation-oppor","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592499460","pubTimestamp":1765963584,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Cencora (COR) has quietly pulled back about 6% over the past month even as its year to date gain sits above 50%, setting up an interesting check on what has actually changed.\nSee our latest analysis for Cencora.\nThat recent 6% pullback and softer 1 month share price return of 5.59% come after a powerful run. The share price is still up strongly year to date and multi year total shareholder returns remain firmly positive, suggesting momentum is cooling rather than breaking.\nIf Cencora’s move...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0058720904.USD":"联博国际健康护理基金A","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4588":"碎股","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","COR":"CENCORA","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","BK4084":"特种房地产投资信托","BK4529":"IDC概念","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4175":"保健护理产品经销商","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD"},"translate_title":"Cencora(COR)：最近的回调是否开启了估值机会？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COR":1.5},"content_text":"Cencora (COR) has quietly pulled back about 6% over the past month even as its year to date gain sits above 50%, setting up an interesting check on what has actually changed. See our latest analysis for Cencora. That recent 6% pullback and softer 1 month share price return of 5.59% come after a powerful run. The share price is still up strongly year to date and multi year total shareholder returns remain firmly positive, suggesting momentum is cooling rather than breaking. If Cencora’s move has you rethinking your healthcare exposure, this could be a good moment to scout other high quality names using our healthcare stocks. With earnings still growing double digits and the share price sitting roughly 14% below analyst targets, has Cencora quietly slipped into undervalued territory, or is the market already factoring in years of future growth? Most Popular Narrative Narrative: 11.6% Undervalued With Cencora last closing at 341.72 dollars against a narrative fair value of 386.60 dollars, the current pullback sits within a still bullish long-term framework.  Cencora's ongoing investment in digital infrastructure and advanced analytics positions the company to capitalize on the accelerating digitization of healthcare and regulatory requirements like the Drug Supply Chain Security Act, improving supply chain efficiency and transparency, which should drive higher net margins and operating income over time.  Read the complete narrative. Want to see what is baked into this optimism? The narrative leans on rising specialty demand, thicker margins, and a future earnings multiple that might surprise you. Result: Fair Value of $386.60 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, accelerated generic adoption and persistent international weakness could compress margins and slow earnings growth, which may challenge assumptions behind the current undervalued narrative. Find out about the key risks to this Cencora narrative. Another View: Market Ratio Sends A Different Signal While the narrative fair value frames Cencora as 11.6 percent undervalued, its current price to earnings ratio of 42.7 times looks stretched versus peers at 22.4 times and a fair ratio of 34.1 times. This suggests downside valuation risk if sentiment normalizes. See what the numbers say about this price — find out in our valuation breakdown. NYSE:COR PE Ratio as at Dec 2025 Build Your Own Cencora Narrative If you see the story differently or want to stress test the assumptions yourself, you can build a custom narrative in just a few minutes: Do it your way. A great starting point for your Cencora research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision. Looking for more investment ideas? Do not stop with a single stock when a world of opportunities is within reach. Use the Simply Wall Street Screener to target strategies that match your goals.  Capture early stage potential by reviewing these 3628 penny stocks with strong financials that pair tiny share prices with balance sheets and cash flows that still look surprisingly resilient. Strengthen your long term income plan by scanning these 13 dividend stocks with yields > 3% that can help support reliable cash returns in changing markets. Position yourself ahead of the next AI wave by assessing these 25 AI penny stocks that are harnessing machine learning to reshape entire industries.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.The New Payments ETF Is Live on NASDAQ:Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.Explore how this launch could reshape portfoliosSponsored ContentNew: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592499460","isCrawlerRequest":true}